Mechanisms of action of mycophenolate mofetil

Nitric oxide: physiology, pathophysiology, and pharmacology.

Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525 · see citing works

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,581 · see citing works

ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY

Giblett, E. R., Anderson, J. E., Cohen, F., et al. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92345-8 · Cited by 1,654 · see citing works

Mycophenolate mofetil and its mechanisms of action

ALLISON, A. C., & Eugui, E. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00188-0 · Cited by 1,433 · see citing works

THE EFFECT OF A HORMONE OF THE ADRENAL CORTEX (17-HYD ROXY-11-DEHYDROCORTICOSTERONE: COMPOUND E) AND OF PITUITARY ADRENOCORTICOTROPIC HORMONE ON RHEUMATOID ARTHRITIS

Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00526-3 · Cited by 1,175 · see citing works

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

Dillon, S. R., Sprecher, C. A., Hammond, A. J., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S., Haugen, H. S., Maurer, M. F., Harder, B., Johnston, J. V., et al. (2004) · Nature Immunology · doi:10.1038/ni1084 · Cited by 1,014 · see citing works

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

Zheng, L., Nukuna, B. N., Brennan, M., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21109 · Cited by 735 · see citing works

A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus

Chan, O. T. M., Hannum, L. G., Haberman, A. M., Madaio, M. P., & Shlomchik, M. J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1639 · Cited by 698 · see citing works

The purine path to chemotherapy

Elion, G. B. (1989) · Science · doi:10.1126/science.2649979 · Cited by 687 · see citing works

Prolonged Survival of Human-Kidney Homografts by Immunosuppressive Drug Therapy

Murray, J. E., Merrill, J. P., Harrison, J. H., Wilson, R. E., & Dammin, G. J. (1963) · New England Journal of Medicine · doi:10.1056/nejm196306132682401 · Cited by 550 · see citing works

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S., & Iwakura, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035999100 · Cited by 490 · see citing works

Characterization of human type I and type II IMP dehydrogenases.

Carr, S. F., Papp, E., Wu, J., et al. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74247-1 · Cited by 431 · see citing works

Immunosuppressive drugs: the first 50 years and a glance forward

ALLISON, A. C. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00186-7 · Cited by 351 · see citing works

Perspectives bone histomorphometry in glucocorticoid-induced osteoporosis

Dempster, D. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040202 · Cited by 319 · see citing works

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.

Morabito, L., Montesinos, M. C., Schreibman, D., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1554 · Cited by 262 · see citing works

Sweet 'n' sour: the impact of differential glycosylation on T cell responses

Daniëls, M. A., Hogquist, K. A., & Jameson, S. C. (2002) · Nature Immunology · doi:10.1038/ni1002-903 · Cited by 254 · see citing works

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

Utimura, R., Fujihara, C. K., Mattar, A. L., Malheiros, D. M. A. C., Noronha, I. D. L., & Zatz, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00736.x · Cited by 194 · see citing works

Advances in Chemotherapy of Cancer in Man

Farber, S., Toch, R., Sears, E. M., & Pinkel, D. (1956) · Advances in cancer research · doi:10.1016/s0065-230x(08)60721-6 · Cited by 194 · see citing works

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

Villadsen, L. S., Schuurman, J., Beurskens, F. J. M., Dam, T. N., Dagnæs‐Hansen, F., Skov, L., Rygaard, J., Voorhorst‐Ogink, M. M., Gerritsen, A. F., van Dijk, M. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318986 · Cited by 193 · see citing works

Interleukin-15: a new cytokine target for the treatment of inflammatory diseases

McInnes, I. B. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.04.003 · Cited by 173 · see citing works

Renal fibrosis: an update

Zeisberg, M., Strutz, F. M., & Muller, G. A. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200105000-00004 · Cited by 164 · see citing works

HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS TREATED WITH SIROLIMUS(RAPAMYCIN)

m, C. B., Wilczek, H., Tyd�n, G., ttiger, Y. B., we, J. S., & Groth, C. (1998) · Transplantation · doi:10.1097/00007890-199805150-00023 · Cited by 156 · see citing works

CONTROL OF ANTIDONOR ANTIBODY PRODUCTION WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH CHRONIC REJECTION1

Theruvath, T. P., Saidman, S. L., Mauiyyedi, S., et al. (2001) · Transplantation · doi:10.1097/00007890-200107150-00016 · Cited by 154 · see citing works

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli

Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., & Makino, H. (1999) · Diabetologia · doi:10.1007/s001250051241 · Cited by 151 · see citing works

IMMUNOLOGICAL OBSERVATIONS ON PATENTS WITH LESCH-NYHAN SYNDROME, AND ON THE ROLE OF DE-NOVO PURINE SYNTHESIS IN LYMPHOCYTE TRANSFORMATION

ALLISON, A. C., Watts, R. W. E., Hovi, T., et al. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92661-6 · Cited by 146 · see citing works

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration1

Meier‐Kriesche, H., Steffen, B. J., Hochberg, A. M., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000062833.14843.4b · Cited by 138 · see citing works

Systemic Lupus Erythematosus and Accelerated Atherosclerosis

Hahn, B. H. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038168 · Cited by 136 · see citing works

Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant Patients

Chan, G. L. C., Erdmann, G. R., Gruber, S. A., Matas, A. J., & Canafax, D. M. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03606.x · Cited by 120 · see citing works

B cells as therapeutic targets for rheumatic diseases

Looney, R. J., Anolik, J. H., & Sanz, I. (2004) · Current Opinion in Rheumatology · doi:10.1097/00002281-200405000-00003 · Cited by 116 · see citing works

Mycophenolates in transplantation

Sollinger, H. W. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00203.x · Cited by 109 · see citing works

Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.

Dayton, J. S., Turka, L. A., Thompson, C. B., et al. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09004-2 · Cited by 105 · see citing works

Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts

Räisänen-Sokolowski, A. K., Vuoristo, P., Myllärniemi, M., et al. (1995) · Transplant Immunology · doi:10.1016/0966-3274(95)80021-2 · Cited by 100 · see citing works

Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells

Blaheta, R. A., Leckel, K., Wittig, B. M., et al. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01984-8 · Cited by 91 · see citing works

Mycophenolic acid antagonizes the activation of cultured human mesangial cells

Dubus, I., Vendrely, B., Christophe, I., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00514.x · Cited by 83 · see citing works

MYCOPHENOLATE MOFETIL: A PROMISING NEW IMMUNOSUPPRESSANT THAT DOES NOT CAUSE BONE LOSS IN THE RAT1,2

Dissanayake, I. R., Goodman, G. R., Bowman, A. R., Yanfei, Pun, S., Jee, W. S. S., & Epstein, S. (1998) · Transplantation · doi:10.1097/00007890-199801270-00025 · Cited by 81 · see citing works

MYCOPHENOLIC ACID, AN INHIBITOR OF IMP DEHYDROGENASE THAT IS ALSO AN IMMUNOSUPPRESSIVE AGENT, SUPPRESSES THE CYTOKINE-INDUCED NITRIC OXIDE PRODUCTION IN MOUSE AND RAT VASCULAR ENDOTHELIAL CELLS

Senda, M., DeLustro, B., Eugui, E. M., et al. (1995) · Transplantation · doi:10.1097/00007890-199511270-00015 · Cited by 80 · see citing works

Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts

Heemann, U. W., Azuma, H., Hamar, P., et al. (1996) · Transplant Immunology · doi:10.1016/s0966-3274(96)80039-6 · Cited by 69 · see citing works

THE EFFECT OF AMINOMETHYLPTEROYLGLUTAMIC ACID ON THE DEVELOPMENT OF SKIN HYPERSENSITIVITY AND ON ANTIBODY FORMATION IN GUINEA PIGS

Friedman, R. M., Buckler, C. E., & Baron, S. (1961) · The Journal of Experimental Medicine · doi:10.1084/jem.114.2.173 · Cited by 64 · see citing works

SEQUENTIAL CYTOKINE EXPRESSION IN RENAL ALLOGRAFTS IN RATS IMMUNOSUPPRESSED WITH MAINTENANCE CYCLOSPORINE OR MYCOPHENOLATE MOFETIL1

Nadeau, K. C., Azuma, H., & Tilney, N. L. (1996) · Transplantation · doi:10.1097/00007890-199611150-00034 · Cited by 49 · see citing works

URINARY NITRATE EXCRETION IS A NONINVASIVE INDICATOR OF ACUTE CARDIAC ALLOGRAFT REJECTION AND NITRIC OXIDE PRODUCTION IN THE RAT

Winlaw, D. S., Schyvens, C. G., Smythe, G. A., et al. (1994) · Transplantation · doi:10.1097/00007890-199411150-00010 · Cited by 48 · see citing works

Mechanisms of action of mycophenolate mofetil in preventing chronic rejection

Allison, A. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)03538-8 · Cited by 34 · see citing works

Two Lessons From the Interface of Genetics and Medicine

ALLISON, A. C. (2004) · Genetics · doi:10.1534/genetics.166.4.1591 · Cited by 32 · see citing works

Antipurines and Purine Metabolism

Wolberg, G. (1988) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-73217-1_24 · Cited by 21 · see citing works

Treatment by Mycophenolate Mofetil of Advanced Graft Vascular Disease in Non‐Human Primate Recipients of Orthotopic Aortic Allografts

Klupp, J., Dambrin, C., Hibi, K., Luna, J., Suzuki, T., Hausen, B., Bı̂rsan, T., van Gelder, T., Fitzgerald, P. J., Berry, G. J., et al. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00148.x · Cited by 21 · see citing works

Organospecific activation of azathioprine in mice: role of liver metabolism in mutation induction

Hrelia, P., Murelli, L., Scotti, M., et al. (1988) · Carcinogenesis · doi:10.1093/carcin/9.6.1011 · Cited by 20 · see citing works

Cholesterol Control: Long-Term Benefit of Pancreas-Kidney Transplantation With FK 506 Immunosuppression

Burke, G. W., Ciancio, G., Alejandro, R., et al. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(97)01381-x · Cited by 19 · see citing works

Mycophenolic Acid and Some Antioxidants Induce Differentiation of Monocytic Lineage Cells and Augment Production of the IL‐1 Receptor Antagonist

Waters, R. V., WEBSTER, D., & ALLISON, A. C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17151.x · Cited by 16 · see citing works

Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control

Eugui, E. M. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)03539-x · Cited by 15 · see citing works

Moving towards personalized treatments of immune-related adverse events

Esfahani, K., Elkrief, A., Calabrese, C., Lapointe, R., Hudson, M., Routy, B., Miller, W. H., & Calabrese, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0352-8 · Cited by 351 · see citing works

Drug repositioning: Progress and challenges in drug discovery for various diseases

Hua, Y., Dai, X., Xu, Y., Xing, G., Liu, H., Lu, T., Chen, Y., & Zhang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114239 · Cited by 232 · see citing works

Mycophenolate mofetil in the treatment of uveitis in children

Doycheva, D., Deuter, C., Stuebiger, N., Biester, S., & Zierhut, M. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.094698 · Cited by 106 · see citing works

Mycophenolate Mofetil for the Treatment of Uveitis

Teoh, S. C., Hogan, A. C., Dick, A. D., & Lee, R. W. J. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.03.004 · Cited by 87 · see citing works

Immune responses and immunosuppressive strategies for adeno-associated virus-based gene therapy for treatment of central nervous system disorders: current knowledge and approaches

Prasad, S., Dimmock, D. P., Greenberg, B., Walia, J. S., Sadhu, C., Tavakkoli, F., & Lipshutz, G. S. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.138 · Cited by 81 · see citing works

Immunomodulation in Administration of RAAV: Preclinical and Clinical Adjuvant Pharmacotherapies

Chu, W. S., & Ng, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658038 · Cited by 59 · see citing works

Antimetabolite drugs exhibit distinctive immunomodulatory mechanisms and effects on the intestinal microbiota in experimental autoimmune uveitis

Llorenç, V., Nakamura, Y., Metea, C., Karstens, L., Molins, B., & Lin, P. (2022) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.63.3.30 · Cited by 20 · see citing works

Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil

Sanquer, S., Breil, M., Baron, C., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90085-1 · Cited by 86 · see citing works

Inhibition of Inosine Monophosphate Dehydrogenase Activity by the Plasma of Heart Transplant Recipients Receiving Mycophenolate Mofetil

Griesmacher, A., Weigel, G., Seebacher, G., et al. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5381-6_104 · Cited by 4 · see citing works

Mycophenolic acid exposure and complement fraction C3 influence inosine 5′-monophosphate dehydrogenase activity in systemic lupus erythematosus

Mino, Y., Naito, T., Shimoyama, K., et al. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216667753 · Cited by 2 · see citing works

[Mycophenolate mofetil--a new immunosuppressive agent].

Bergan, S., Albrechtsen, D., & Fauchald, P. (1996) · PubMed

Mycophenolate-mofetil

Sievers, T. M., Rossi, S. J., Ghobrial, R. M., et al. (2023) · Reactions Weekly · doi:10.1007/s40278-023-51160-7 · Cited by 13 · see citing works